06:30Wyss Bioinspired Approach to Sepsis Therapy
From the creator
Wyss Institute Founding Director Don Ingber, Senior Staff Scientist Michael Super and Technology Development Fellow Joo Kang explain how they engineered the Mannose-binding lectin (MBL) protein to bind to a wide range of sepsis-causing pathogens and then safely remove the pathogens from the bloodstream using a novel microfluidic spleen-like device. For more information, please visit wyss.harvard.edu.
Published 2014-09-14 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





